Terug
Dagbereik
€ 16,12
€ 17,20
52-Weeksbereik
€ 15,08
€ 38,99
Volume
1.732.945
50D / 200D Gem.
€ 25,26
/
€ 26,99
Vorige Slotkoers
€ 16,55
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -1,0 | 0,3 |
| P/B | 0,6 | 2,9 |
| ROE % | -46,2 | 3,7 |
| Net Margin % | -41,5 | 3,8 |
| Rev Growth 5Y % | 12,6 | 10,0 |
| D/E | 1,5 | 0,2 |
Koersdoel Analisten
Hold
€ 30,00
+85.5%
Forward K/W
7,7
Forward WPA
€ 2,15
WPA Groei (sch.)
+0,0%
Omzet Sch.
2,8 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 3,10
€ 3,07 – € 3,12
|
3,1 B | 1 |
| FY2029 |
€ 3,78
€ 3,74 – € 3,80
|
3,1 B | 1 |
| FY2028 |
€ 3,47
€ 3,44 – € 3,49
|
3 B | 1 |
Belangrijkste Punten
Revenue grew 12,60% annually over 5 years — strong growth
Negative free cash flow of -83,00M
PEG of 0,04 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 14,49%
Capital efficient — spends only 6,89% of revenue on capex
Groei
Revenue Growth (5Y)
12,60%
Revenue (1Y)-1,89%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-46,15%
ROIC-14,59%
Net Margin-41,45%
Op. Margin-33,67%
Veiligheid
Debt / Equity
1,46
Current Ratio1,50
Interest Coverage-5,18
Waardering
P/E Ratio
-0,97
P/B Ratio0,57
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1,89% | Revenue Growth (3Y) | -4,57% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 12,60% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 2,73B | Net Income (TTM) | -1,13B |
| ROE | -46,15% | ROA | -19,62% |
| Gross Margin | 46,67% | Operating Margin | -33,67% |
| Net Margin | -41,45% | Free Cash Flow (TTM) | -83,00M |
| ROIC | -14,59% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,46 | Current Ratio | 1,50 |
| Interest Coverage | -5,18 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -0,97 | P/B Ratio | 0,57 |
| P/S Ratio | 0,40 | PEG Ratio | 0,04 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,10B | Enterprise Value | 3,74B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,73B | 2,78B | 3,00B | 3,27B | 1,70B |
| Net Income | -1,13B | -2,05B | -10,10M | 548,70M | 704,20M |
| EPS (Diluted) | -16,69 | -30,54 | -0,15 | 9,56 | 16,43 |
| Gross Profit | 1,27B | 1,29B | 1,50B | 1,94B | 1,28B |
| Operating Income | -919,20M | -1,96B | 139,10M | 843,70M | 906,00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5,77B | 6,42B | 8,56B | 8,86B | 2,43B |
| Total Liabilities | 3,85B | 3,44B | 3,56B | 3,92B | 501,00M |
| Shareholders' Equity | 1,92B | 2,98B | 5,01B | 4,93B | 1,93B |
| Total Debt | 2,80B | 2,68B | 2,61B | 2,85B | 139,30M |
| Cash & Equivalents | 169,80M | 98,30M | 118,90M | 292,90M | 802,80M |
| Current Assets | 1,45B | 1,22B | 1,31B | 1,58B | 1,44B |
| Current Liabilities | 966,10M | 998,80M | 833,80M | 1,01B | 323,50M |